Treatment for male anti-NMDA receptor encephalitis patients

March 14, 2018

Anti-NMDA receptor encephalitis is an acute disease occurring when antibodies produced by the body's own immune system attack N-methyl-D-aspartate (NMDA) receptors in the brain. Recovery from this disease occurs as a multistage process, which can take from several months to several years after disease onset. Some Anti-NMDA receptor encephalitis patients have detectable tumors, and they had significant improvement after tumor resection. It reveals that this tumor is the cause of this disorder. For other patients, the cause is often unknown. There are several reports indicating that it is related to vaccination.

The treatments for this disorder include first-line immunotherapies: steroids, intravenous immunoglobulin (IVIG) or plasmapheresis (or plasma exchange); and second-line immunotherapy such as rituximab or cyclophosphamide. In addition, it is suggested that tumors be resected from these patients. The choice of treatments may be a potential factor that facilitates an early recovery from anti-NMDA receptor encephalitis. Studies on the efficacies of treatments for anti-NMDA receptor encephalitis have revealed that patients receiving at least two different forms of therapy may have higher efficacy rates than patients receiving a single form of therapy

Since this disorder occurs more often in females than in males, we are interested in whether the efficacy of treatment depends on the gender of the patient. The efficacy of the treatments including intravenous immunoglobulin, plasma exchange, plasmapheresis, rituximab or cyclophosphamide for male anti-NMDA receptor encephalitis patients without tumor is compared. The results reveal that we it is possible to find the effective treatment strategy for a specific group of patients although this treatment strategy may not always be effective for the patients that are not in this specific group. Most studies for the anti-NMDA receptor encephalitis provided an overview statistical result for this disease but did not focus on any patient-specific treatment discussion. This study can provide a patient-specific treatment strategy since the efficacy rate of plasmapheresis (or plasma exchange) is not inferior to those of intravenous immunoglobulin and rituximab (or cyclophosphamide) for male patients without tumor.
For more information on this study, please visit:


Wang H. (2018). Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker, Curr Med Chem., Vol. 25, DOI: 10.2174/0929867325666180221142623

Bentham Science Publishers

Related Plasma Articles from Brightsurf:

Plasma treatments quickly kill coronavirus on surfaces
Researchers from UCLA believe using plasma could promise a significant breakthrough in the fight against the spread of COVID-19.

Fighting pandemics with plasma
Scientists have long known that ionized gases can kill pathogenic bacteria, viruses, and some fungi.

Topological waves may help in understanding plasma systems
A research team has predicted the presence of 'topologically protected' electromagnetic waves that propagate on the surface of plasmas, which may help in designing new plasma systems like fusion reactors.

Plasma electrons can be used to produce metallic films
Computers, mobile phones and all other electronic devices contain thousands of transistors, linked together by thin films of metal.

Plasma-driven biocatalysis
Compared with traditional chemical methods, enzyme catalysis has numerous advantages.

How bacteria protect themselves from plasma treatment
Considering the ever-growing percentage of bacteria that are resistant to antibiotics, interest in medical use of plasma is increasing.

A breakthrough in the study of laser/plasma interactions
Researchers from Lawrence Berkeley National Laboratory and CEA Saclay have developed a particle-in-cell simulation tool that is enabling cutting-edge simulations of laser/plasma coupling mechanisms.

Researchers turn liquid metal into a plasma
For the first time, researchers at the University of Rochester's Laboratory for Laser Energetics (LLE) have found a way to turn a liquid metal into a plasma and to observe the temperature where a liquid under high-density conditions crosses over to a plasma state.

How black holes power plasma jets
Cosmic robbery powers the jets streaming from a black hole, new simulations reveal.

Give it the plasma treatment: strong adhesion without adhesives
A Japanese research team at Osaka University used plasma treatment to make fluoropolymers and silicone resin adhere without any adhesives.

Read More: Plasma News and Plasma Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to